<code id='16884D8A0F'></code><style id='16884D8A0F'></style>
    • <acronym id='16884D8A0F'></acronym>
      <center id='16884D8A0F'><center id='16884D8A0F'><tfoot id='16884D8A0F'></tfoot></center><abbr id='16884D8A0F'><dir id='16884D8A0F'><tfoot id='16884D8A0F'></tfoot><noframes id='16884D8A0F'>

    • <optgroup id='16884D8A0F'><strike id='16884D8A0F'><sup id='16884D8A0F'></sup></strike><code id='16884D8A0F'></code></optgroup>
        1. <b id='16884D8A0F'><label id='16884D8A0F'><select id='16884D8A0F'><dt id='16884D8A0F'><span id='16884D8A0F'></span></dt></select></label></b><u id='16884D8A0F'></u>
          <i id='16884D8A0F'><strike id='16884D8A0F'><tt id='16884D8A0F'><pre id='16884D8A0F'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:91926

          How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

          advertisement

          For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Massive project maps cells in human brain in unprecedented detail
          Massive project maps cells in human brain in unprecedented detail

          AdobeThebrainremainsboththebody’smostimportantorgananditsleastunderstood.Butadraftatlasofthehumanbra

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Will the IRA bring competition to the biologics market?

          AdobeOnAug.29,Medicarereleaseditshighlyanticipatedlistof10therapiesforwhichitplanstoestablishapriceb